SB202190
To Order Contact us: stephen@expresspharmapulse.com
![]() SB202190 (FHPI) |
|||
A1632-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 113 |
Description: SB202190 (FHPI) is a potent p38 MAPK inhibitor that specifically inhibits p38? and p38? with IC50 values of 50 and 100 nM, respectively [1].SB202190 has been reported to potently enhance the growth of leukemia cell lines THP-1 and MV4-11. |
![]() SB202190 (p38 MAP kinase inhibitor) |
|||
SIH-473-25MG | Stressmarq | 25 mg | EUR 429 |
|
|||
Description: The substance SB202190 is a p38 map kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is pale yellow solid which is soluble in methanol, DMSO or acetone; slightly soluble in ethyl acetate. |
![]() SB202190 (p38 MAP kinase inhibitor) |
|||
SIH-473-5MG | Stressmarq | 5 mg | EUR 160 |
|
|||
Description: The substance SB202190 is a p38 map kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is pale yellow solid which is soluble in methanol, DMSO or acetone; slightly soluble in ethyl acetate. |